OurCrowd, the global crowdfunding venture investing platform and Israel’s leading venture investor, will feature Dr. Ferid Murad, 1998 Nobel prize winner in medicine, among the experts at the OurCrowd Global Investor Summit on Feb. 13. Murad will discuss how technology can help prevent the development of deadly diseases. The subject has been catapulted back into the headlines with the outbreak of the deadly Coronavirus in China.
Dr. Murad recently joined the board of SaNOtize, an OurCrowd portfolio company using new technology to treat skin and upper respiratory diseases with an infectious component to them. Dr. Murad will be talking about superbugs, the danger they pose to humanity, and new methods developed by SaNOtize that avoid the use of antibiotics.
Dr. Murad will join other OurCrowd medtech companies in the “High-Tech Horror Show” session that addresses how Armageddon can be postponed as tech tackles our worst fears including disease, climate change, gene tinkering, fake news and cyberhacking.
Other medtech experts appearing at the Summit include:
Prof. Ruth Arnon, Dept of Immunology, Weizmann Institute, co-creator of the Copaxone treatment for multiple sclerosis and developer of a new universal flu vaccine, who will receive the Maimonides Award for Lifetime Achievement
Dr. Eran Eden, Co-founder and CEO of MeMed, whose technology enables early prescription and preventing misuse of antibiotics with personalized diagnostics by decoding the human immune system
Eyal Gura, founder and chairman of Zebra Medical Vision, which has won 5 FDA approvals for its AI-powered diagnostic imaging tools
Uzi Sofer, CEO and chairman of Alpha Tau, whose Alpha Dart targeted cancer radiation treatment showed tumor shrinkage in 100% of cases in its first clinical trial
For interview opportunities with these and other medtech experts at the OurCrowd Global Investor summit, apply now for your VIP media pass at summit.ourcrowd.com.
Source: OurCrowd Global Investor Summit